Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow United Health Products, Inc.

Get SEC filing alerts via email and in your feed for United Health Products, Inc.

UEEC

United Health Products, Inc.

About United Health Products, Inc.

United Health Products, Inc. develops and markets patented hemostatic gauze derived from cotton for wound care and bleeding control. Focused on obtaining FDA Class III approval, its primary product, CelluSTAT, targets surgical, trauma, and medical markets. The company emphasizes regulatory compliance, strategic partnerships, and intellectual property protection, operating with limited personnel and financial resources while seeking to expand into international markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from United Health Products, Inc.

1
1
United Health Products, Inc. United Health Products Reports $315,842 Net Loss in Q1 2026, Focuses on Regulatory Approval for CelluSTAT

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
United Health Products, Inc. United Health Products Reports $2.67 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | about 2 months ago | 0 comments

3
1
United Health Products, Inc. United Health Products Reports Zero Revenue and Increased Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
United Health Products, Inc. United Health Products Reports $0 Revenue and Increased Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
United Health Products, Inc. United Health Products Reports $1.53 Million Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
United Health Products, Inc. United Health Products Reports Decreased Net Loss and Focuses on Regulatory Approvals for CelluSTAT

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
United Health Products, Inc. United Health Products Reports Significant Financial Challenges, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments